| Withrow and MacEwen's Small Animal Clinical Oncology-E-Book SJ Withrow, DM Vail, R Page Elsevier Health Sciences, 2012 | 1403 | 2012 |
| Spontaneously occurring tumors of companion animals as models for human cancer DM Vail, EG Macewen Cancer investigation 18 (8), 781-792, 2000 | 670 | 2000 |
| The dog as a cancer model C Khanna, K Lindblad-Toh, D Vail, C London, P Bergman, L Barber, ... Nature biotechnology 24 (9), 1065-1066, 2006 | 427 | 2006 |
| Evaluation of a 6‐month chemotherapy protocol with no maintenance therapy for dogs with lymphoma LD Garrett, DH Thamm, R Chun, R Dudley, DM Vail Journal of veterinary internal medicine 16 (6), 704-709, 2002 | 392 | 2002 |
| Response evaluation criteria for solid tumours in dogs (v1. 0): a Veterinary Cooperative Oncology Group (VCOG) consensus document SM Nguyen, DH Thamm, DM Vail, CA London Veterinary and comparative oncology 13 (3), 176-183, 2015 | 388 | 2015 |
| Canine lymphoma and lymphoid leukemia DM Vail Small animal clinical oncology, 699-733, 2007 | 329 | 2007 |
| Withrow and MacEwen's small animal clinical Oncology-E-Book DM Vail, DH Thamm, JM Liptak Elsevier Health Sciences, 2019 | 299 | 2019 |
| Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours C London, T Mathie, N Stingle, C Clifford, S Haney, MK Klein, L Beaver, ... Veterinary and comparative oncology 10 (3), 194-205, 2012 | 278 | 2012 |
| Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats DM Vail, AS Moore, GK Ogilvie, LM Volk Journal of veterinary internal medicine 12 (5), 349-354, 1998 | 261 | 1998 |
| Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986–1996) AE Hershey, KU Sorenmo, MJ Hendrick, FS Shofer, DM Vail Journal of the American Veterinary Medical Association 216 (1), 58-61, 2000 | 252 | 2000 |
| Hematopoietic tumors DM Vail, DH Thamm, JM Liptak Withrow and MacEwen's small animal clinical oncology, 688, 2019 | 247 | 2019 |
| Prednisone and vinblastine chemotherapy for canine mast cell tumor—41 cases (1992–1997) DH Thamm, EA Mauldin, DM Vail Journal of veterinary internal medicine 13 (5), 491-497, 1999 | 247 | 1999 |
| Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies DM Vail, MA Amantea, GT Colbern, FJ Martin, RA Hilger, PK Working Seminars in oncology 31, 16-35, 2004 | 240 | 2004 |
| Tumors of the skin and subcutaneous tissues DM Vail, SJ Withrow Withrow, SJ; Macewen, EG Small animal clinical oncology 4, 375-401, 2007 | 235 | 2007 |
| Hematopoietic tumors. DM Vail | 233 | 2000 |
| Response evaluation criteria for peripheral nodal lymphoma in dogs (v1. 0)–a Veterinary Cooperative Oncology Group (VCOG) consensus document DM Vail, GM Michels, C Khanna, KA Selting, CA London, ... Veterinary and comparative oncology 8 (1), 28-37, 2010 | 224 | 2010 |
| Amputation and cisplatin for treatment of canine osteosarcoma RC Straw, SJ Withrow, SL Richter, BE Powers, MK Klein, NC Postorino, ... Journal of Veterinary Internal Medicine 5 (4), 205-210, 1991 | 216 | 1991 |
| Small animal clinical oncology DM Vail, DH Thamm, JM Liptak Philadelphia, WB Saunders 28, 611-624, 2001 | 200 | 2001 |
| Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases DH Thamm, MM Turek, DM Vail Journal of Veterinary Medical Science 68 (6), 581-587, 2006 | 190 | 2006 |
| Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation DH Thamm, ID Kurzman, I King, Z Li, M Sznol, RR Dubielzig, DM Vail, ... Clinical cancer research 11 (13), 4827-4834, 2005 | 189 | 2005 |
